InsidersTradesSigma
Browse the complete record of transactions filed by Charles Ballantyne, Chief Financial Officer. Officer active across 2 companies, notably Hansa Biopharma AB. Aggregated, 1 reports have been recorded. The latest transaction was filed on 7 November 2025 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
1 of 1 declaration
Charles Ballantyne is the Chief Financial Officer of Hansa Biopharma AB, a company specializing in the development of biological therapies. As CFO, he is responsible for the financial management and economic strategy of the company. His expertise in the financial field is essential in guiding Hansa Biopharma in its growth initiatives.